You are here

  • Home
  • Archive
  • Volume 77, Issue 5
  • Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

Citation Tools

Article menu

Download PDFPDF

XML
Clinical and epidemiological research
Extended report
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Morand EF, Trasieva T, Berglind A, et al
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab
Annals of the Rheumatic Diseases 2018;77:706-713.